Canadian Urological Association / L'Association des urologues du Canada

Canadian Urological Association (CUA)

Health EN ↓ 102 Folgen

The official podcast of the Canadian Urological Association (CUA).Le podcast officiel de l'association des urologues du Canada (AUC).

Autor

Canadian Urological Association / L'Association des urologues du Canada

Kategorie

Health

Podcast-Website

cua.simplecast.com

Neueste Folge

4. Mär 2025

Wo hören?

Podcasts in der App Replaio Radio Bald verfügbar

Podcasts kommen bald in die App. Installiere sie jetzt und erlebe als Erster einen ganz neuen Blick auf Podcasts

Bei Google Play herunterladen Kostenlos installieren Android fast 10 Mio. Downloads · Bewertung 4,8 iOS bald

Folgen

CUA Highlights of GU ASCO 2022 - Prostate Cancer Session - French 22.02.2022

Disclosures: Anil Kapoor Advisory Honoraria: BMS, MERCK, Ipsen, Eisai, Abbvie, Janssen, Astellas, Astra-Zeneca Speakers Bureau: Merck, Ipsen, Eisai Investments: Verity, Point Biopharma Clinical Trials: CCTG, Eisai, Janssen, Merck Leadership/Board Position Tamim Niazi Honoraria/ research funding: Abbvie, Astellas, Bayer, Janssen, Sanofi, Merck, AstraZeneca, TerSera, Knight Therapeutics, Amgen, Tolm...

CUA Highlights of GU ASCO 2022 - Kidney Cancer Session - French 22.02.2022

Disclosures: Anil Kapoor Advisory Honoraria: BMS, MERCK, Ipsen, Eisai, Abbvie, Janssen, Astellas, Astra-Zeneca Speakers Bureau: Merck, Ipsen, Eisai Investments: Verity, Point Biopharma Clinical Trials: CCTG, Eisai, Janssen, Merck Leadership/Board Position Christian Kollmannsberger Consultant: Pfizer, Merck, Sanofi, Astellas, BMS, Ipsen, Eisai, Bayer Honoraria for presentations: Pfizer, Ipsen, Eisa...

CUA Highlights of GU ASCO 2022 - Bladder Cancer Session - French 22.02.2022

Disclosures: Anil Kapoor Advisory Honoraria: BMS, MERCK, Ipsen, Eisai, Abbvie, Janssen, Astellas, Astra-Zeneca Speakers Bureau: Merck, Ipsen, Eisai Investments: Verity, Point Biopharma Clinical Trials: CCTG, Eisai, Janssen, Merck Leadership/Board Position Nimira Alimohamed Advisory Board/Consultancy roles: Pfizer, EMD Serono, Merck, Seagen Wassim Kassouf No disclosures Alejandro Berlin No disclosu...

CUA Practice Changing Publications (PCP) - Endourology (Surgical Management of BPH) 15.02.2022

Disclosures: Dean Elterman Advisory Boards/ Speakers Bureaus: Astellas, Boston Scientific, Duchesnay, Pfizer, Procept, Prodeon, Olympus, Medtronic, Urotronic, Zeneflow Kevin Zorn Advisory Board: BSCI, Procept, Zenflow

V2P2 2022 - An Update in Advanced Prostate Cancer 10.02.2022

Disclosures: Fred Saad Grants/Honoraria: Amgen, Astellas, AstraZeneca, Bayer, Merck, Novartis, Janssen, Myovant, Sanofi Eleni Efstathiou Research Support/P.I.: Janssen, Sanofi-Genzyme, Astellas/Medivation, Oric-Pharma, Nuvation Scientific Advisory Board/Honoraria: Janssen, Sanofi-Genzyme, Bayer, Oric Pharma, Marck, AAA-Novartis, Genetech, Astra-Zeneca, Astellas, Pfizer, Myovant

V2P2 2022 - An Update in Advanced Prostate Cancer - French 10.02.2022

Disclosures: Fred Saad Grants/Honoraria: Amgen, Astellas, AstraZeneca, Bayer, Merck, Novartis, Janssen, Myovant, Sanofi Eleni Efstathiou Research Support/P.I.: Janssen, Sanofi-Genzyme, Astellas/Medivation, Oric-Pharma, Nuvation Scientific Advisory Board/Honoraria: Janssen, Sanofi-Genzyme, Bayer, Oric Pharma, Marck, AAA-Novartis, Genetech, Astra-Zeneca, Astellas, Pfizer, Myovant 

Practice Changing Publications (PCP): Update in Kidney Cancer 01.02.2022

Disclosures: Anil Kapoor Advisory Honoraria: BMS, MERCK, Ipsen, Eisai, Abbvie, Janssen, Astellas, Astra-Zeneca Speakers Bureau: Merck, Ipsen, Eisai Investments: Verity, Point Biopharma Clinical Trials: CCTG, Eisai, Janssen, Merck Leadership/Board Position: Kidney Cancer Canada Luke Lavallee Advisory Board: Sanofi, Ferring, Knight, Bayer, Janssen, Astellas Grant/Honorarium: Sanofi

The Year Ahead 2022: Global Economic Outlook 24.01.2022

Disclosures: Derek Henderson Banking relationship with TD Christopher French Advisory Boards: Astellas, AstraZeneca

Practice Changing Publications (PCP): Female Urology 07.12.2021

Disclosures: Martine Jolivet Advisory Board and/or Speaker Bureau: Allergan/Abbvie Genevieve Nadeau Clinical Trials: Contiform International Advisory Board and/or Speaker Bureau: Pfizer, Boston Scientific, Astellas, Allergan/Abbvie, Searchlight Pharma

Management of Medication-Refractory Overactive Bladder (OAB) - French 24.11.2021

Disclosures: Kevin Carlson Advisroy Board/Payment: Abbvie Richard Baverstock Advisory Board: Abbvie Speakers Bureau: Astellas, Boston Scientific, Abbvie Payment: Abbvie, Astellas, Bsci Greg Baily Advisory Board/ Speaker Bureau: Abbvie

Management of Medication-Refractory Overactive Bladder (OAB) 24.11.2021

Disclosures: Kevin Carlson Advisory Board/Payment: Abbvie Richard Baverstock Advisory Board: Abbvie Speakers Bureau: Astellas, Boston Scientific, Abbvie Payment: Abbvie, Astellas, Bsci Greg Baily Advisory Board/ Speaker Bureau: Abbvie

Precision Medicine in Prostate Cancer: Multidisciplinary Perspectives in Identifying, Managing and Optimizing Patient Care (English) 18.11.2021

Disclosures: Neil Fleshner Payment: Astellas, Janssen, Abbvie, Sanofi, Merck Grant/Honorarium: Astellas, Janssen, Bayer Investments: Verity Pharma Clinical Trials: Astellas, Janssen, Bayer Leadership Position: Point Biopharma Urban Emmenegger Advisory Boards: Amgen, Astellas, Bayer, Ferring, Janssen, Sanofi, Merck, AstraZeneca Payment: Astellas, Bayer, Ferring, Janssen, Sanofi, Merck, AstraZeneca...

Precision Medicine in Prostate Cancer: Multidisciplinary Perspectives in Identifying, Managing and Optimizing Patient Care (French) 17.11.2021

Conflits d'interests: Fred Saad Subventions/honoraires: Amgen, Astellas, AstraZeneca, Bayer, Merck, Novartis, Janssen, Myovant, Sanofi Zineb Hamilou Remuneration: AstraZeneca, Sengen, EMD Serono Essai Clinique: Sengen Evan Weber Subventions ou des honoraires: AstraZeneca/Merck

V2P2 2022 - Female Sexual Dysfunction [FR] 15.11.2021

Disclosures: Ashley Cox Advisory Board: Abbvie, Allergan Rachel S. Rubin Speakers Bureau: Sprout Clinical Trials: Ipsen, Abbvie Leadership/Board Position: ISSWSH

V2P2 2022 - Female Sexual Dysfunction 15.11.2021

Disclosures: Ashley Cox Advisory Board: Abbvie, Allergan Rachel S. Rubin Speakers Bureau: Sprout Clinical Trials: Ipsen, Abbvie Leadership/Board Position: ISSWSH

CUA Practice Changing Publications (PCP): TESTIS CANCER 02.11.2021

Disclosures: Armin Aprikian Advisory boards: Abbvie, Astellas, Bayer Grant/Honorarium: Abbvie, Astellas, Bayer, Sanofi, TerSera Robert Hamilton Advisory boards: Janssen, Astellas, Bayer, TerSera Clinical Trials: Janssen, Bayer, Astellas

CUA Practice Changing Publications (PCP): INFERTILITY 19.10.2021

Disclosures: Armand Zini Shareholder in YAD Tech - a neutraceuticals company Jesse Ory No disclosures

CUA Highlights of ESMO 2021 - Prostate Cancer Session - French 22.09.2021

Disclosures:   Sebastien J. Hotte Research Funding (Institution): Astellas, AstraZeneca, Ayala, Bayer, BMS, Eisai, Exelixis, Janssen, Ipsen, Merck, Roche, Sanofi, SeaGen, SignalChem Grants (Institution): BMS, Janssen, Bayer Consultant/Honoraria (Self): Astellas, AtraZeneca ,Bayer, BMS, Eisai, Ipsen, Janssen, Merck, Pfizer, Roche, SeaGen Tamim Nizai Honoraria/Research fun: Abbvie, Sanofi, TerSera,...

CUA Highlights of ESMO 2021 - Bladder Cancer Session - French 22.09.2021

Disclosures: Girish Kilkarni Advisory Boards: Janssen, Merck, Roche, Ferring, Astellas, Theralase Grants/Honoraria: Abbvie, Sanofi, Ferring, TerSera, Knight Therapeutics, Verity Clinical Trials: Merck, Astra Zeneca, Bristol Myers Squibb, Theralase, Janssen, Pfizer Krista Noonan Consulting/Honoraria: AstraZeneca, BMS, Janssen, Merck, Pfizer, EMD Serono Research Support: Roche

CUA Highlights of ESMO 2021 - Kidney Cancer Session - French 22.09.2021

Disclosures:   Michael Leveridge Ipsen - speaker session moderator 2019 Maryam Soleimani Honorarium: Pfizer Grant funding: Abbvie, Astellas, Bayer Himu Lukka No disclosures

CUA Highlights of ESMO 2021 - Kidney Cancer Session 22.09.2021

Disclosures:   Michael Leveridge Ipsen - speaker session moderator 2019 Maryam Soleimani Honorarium: Pfizer Grant funding: Abbvie, Astellas, Bayer Himu Lukka No disclosures

CUA Highlights of ESMO 2021 - Bladder Cancer Session 22.09.2021

Disclosures: Girish Kilkarni Advisory Boards: Janssen, Merck, Roche, Ferring, Astellas, Theralase Grants/Honoraria: Abbvie, Sanofi, Ferring, TerSera, Knight Therapeutics, Verity Clinical Trials: Merck, Astra Zeneca, Bristol Myers Squibb, Theralase, Janssen, Pfizer Krista Noonan Consulting/Honoraria: AstraZeneca, BMS, Janssen, Merck, Pfizer, EMD Serono Research Support: Roche

CUA Highlights of ESMO 2021 - Prostate Cancer Session 22.09.2021

Disclosures:   Sebastien J. Hotte Research Funding (Institution): Astellas, AstraZeneca, Ayala, Bayer, BMS, Eisai, Exelixis, Janssen, Ipsen, Merck, Roche, Sanofi, SeaGen, SignalChem Grants (Institution): BMS, Janssen, Bayer Consultant/Honoraria (Self): Astellas, AtraZeneca ,Bayer, BMS, Eisai, Ipsen, Janssen, Merck, Pfizer, Roche, SeaGen Tamim Nizai Honoraria/Research fun: Abbvie, Sanofi, TerSera,...

CUA Q & A Series | Topic: Delay of Injection 13.07.2021

Delay of Injection (Q&A series) 0:00 - Ricardo Rendon 9:30 - Fred Saad 18:10 - Jasper Yuen

Milestones in Advanced Bladder Cancer 12.07.2021

Podcast Host Disclosures: Dr. Alimohamed has had a consulting or advisory role with Astellas Pharma, AstraZeneca, Janssen, Merck, Pfizer, and Sanofi Canada. Dr. Lalani has received honoraria from Astellas Pharma, Bayer, Bristol-Myers Squibb, Merck, Novartis, Pfizer, Roche/Genentech, and TerSera; has had a consulting or advisory role with Abbvie, Astellas Pharma, Bayer, Bristol-Myers Squibb, Eisai,...

Höre den Podcast Canadian Urological Association (CUA) in Replaio

Radio und Podcasts in einer App - kostenlos und ohne Anmeldung. Installiere sie noch heute und verpasse den Start nicht

Bei Google Play herunterladen

Replaio ist kein Herausgeber von Podcasts; die Namen der Sendungen, Cover und Audioinhalte gehören ihren Autoren und werden über öffentliche RSS-Feeds verbreitet